We are live on
!
Find out more
PVI
Pura Vida Investments Portfolio holdings
AUM
$37M
1-Year Est. Return
63.54%
This Fund
S&P 500
This Quarter
Est. Return
-5.18%
1 Year Est. Return
+63.54%
3 Year Est. Return
+38.32%
5 Year Est. Return
+47.02%
10 Year Est. Return
+2,089.98%
AUM
$2.76B
AUM Growth
-$525M
(-16%)
Cap. Flow
-$439M
Cap. Flow
% of AUM
-15.9%
Top 10 Holdings %
Top 10 Hldgs %
38.29%
Holding
343
New
69
Increased
54
Reduced
100
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VRAY
ViewRay, Inc.
VRAY
|
+$17.9M |
| 2 |
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
|
+$17.3M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$14.1M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$14M |
| 5 |
CUTR
Cutera, Inc.
CUTR
|
+$12.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Seer Inc
SEER
|
+$24.7M |
| 2 |
MAPS
WM TECHNOLOGY INC A
MAPS
|
+$23.4M |
| 3 |
LivaNova
LIVN
|
+$20.2M |
| 4 |
Glaukos
GKOS
|
+$17.5M |
| 5 |
Cooper Companies
COO
|
+$16.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.75% |
| 2 | Consumer Staples | 0.58% |
| 3 | Financials | 0.5% |
| 4 | Consumer Discretionary | 0.42% |
| 5 | Industrials | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TBIO
101
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $6.18M | 0.22% |
31,794
+9,951
| +46% | +$1.55M |
|
|
LONA
102
LeonaBio Inc
LONA
$73.9M
| $6.18M | 0.22% |
+47,430
| New | +$6M |
|
103
Milestone Pharmaceuticals
MIST
$133M
| $6.1M | 0.22% |
931,511
+81,199
| +10% | +$486K |
|
104
PUT
Moderna
MRNA
$25.1B
| $5.89M | 0.21% |
+23,200
| New | +$6.78M |
|
105
Privia Health
PRVA
$2.77B
| $5.76M | 0.21% |
222,493
-196,120
| -47% | -$4.89M |
|
|
HOLX
106
PUT
DELISTED
Hologic
HOLX
| $5.74M | 0.21% |
75,000
-125,000
| -63% | -$9.19M |
|
107
Vertex Pharmaceuticals
VRTX
$131B
| $5.41M | 0.2% |
24,636
-5,364
| -18% | -$1.04M |
|
108
GH Research
GHRS
$1.96B
| $5.31M | 0.19% |
227,427
-152,618
| -40% | -$3.35M |
|
109
PUT
ClearShares Piton Intermediate Fixed Income ETF
PIFI
$97.8M
| $5.2M | 0.19% |
+246,400
| New | +$24.3M |
|
110
Alpha Teknova
TKNO
$397M
| $5.11M | 0.19% |
249,512
-94,529
| -27% | -$2.1M |
|
111
Celldex Therapeutics
CLDX
$3.38B
| $5.09M | 0.18% |
131,771
+54,486
| +71% | +$2.37M |
|
|
ARYD
112
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
| $5.06M | 0.18% |
510,507
-15,710
| -3% | -$156K |
|
|
SONX
113
DELISTED
Sonendo, Inc.
SONX
| $5.05M | 0.18% |
+877,385
| New | +$7.89M |
|
|
NSTG
114
CALL
DELISTED
NanoString Technologies, Inc.
NSTG
| $5.01M | 0.18% |
+118,600
| New | +$5.19M |
|
|
RACB
115
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
| $4.9M | 0.18% |
503,955
-7,525
| -1% | -$74K |
|
|
NYXH
116
Nyxoah
NYXH
$157M
| $4.8M | 0.17% |
220,623
-4,591
| -2% | -$106K |
|
117
CALL
Merck
MRK
$332B
| $4.78M | 0.17% |
+62,300
| New | +$4.96M |
|
118
CALL
Adaptive Biotechnologies
ADPT
$3.91B
| $4.54M | 0.16% |
161,800
+121,800
| +305% | +$3.73M |
|
119
CALL
Inspire Medical Systems
INSP
$1.68B
| $4.53M | 0.16% |
+19,700
| New | +$4.81M |
|
|
QTNT
120
CALL
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $4.27M | 0.15% |
41,223
+10,425
| +34% | +$999K |
|
121
AtaiBeckley Inc
ATAI
$2.69B
| $4.22M | 0.15% |
552,781
-739,091
| -57% | -$8.97M |
|
122
Procept Biorobotics
PRCT
$1.26B
| $3.88M | 0.14% |
155,214
-4,786
| -3% | -$177K |
|
123
PUT
Nektar Therapeutics
NKTR
$2.58B
| $3.83M | 0.14% |
+18,905
| New | +$4.1M |
|
|
ISEE
124
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $3.81M | 0.14% |
228,100
-377,700
| -62% | -$6.19M |
|
125
Incyte
INCY
$24.3B
| $3.62M | 0.13% |
+49,278
| New | +$3.32M |
|
Similar funds
CI
RH
ICP
GC
BAM
CM
AP
ACM
Pura Vida Investments's Q4 2021 Portfolio in Review
As of Q4 2021, Pura Vida Investments held 343 positions worth $2.76B, down 16% from $3.29B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Pura Vida Investments withdrew a net $439M in Q4 2021, closing 111 positions and reducing 100 holdings. Its most notable exit was Seer Inc, an estimated $24.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 33% a quarter earlier, followed by Consumer Staples and Financials.
Against the trend, Pura Vida Investments opened a new position in BioMarin Pharmaceuticals worth $15M.
- Pura Vida Investments's largest Q4 2021 buy was BioMarin Pharmaceuticals: 170,210 shares worth $15M.
- Pura Vida Investments added most to ViewRay, Inc. in Q4 2021, an estimated $17.9M increase.
- Pura Vida Investments's biggest Q4 2021 reduction was LivaNova, cutting an estimated $20.2M.
- Pura Vida Investments fully exited Seer Inc in Q4 2021, selling an estimated $24.7M.
- Pura Vida Investments's ten largest holdings make up 38% of its $2.76B portfolio in Q4 2021.
- Pura Vida Investments opened 69 new positions and closed 111 in Q4 2021.
- Pura Vida Investments's portfolio value fell 16% quarter-over-quarter to $2.76B.
Based on Pura Vida Investments's 13F filing for Q4 2021, filed 14 Feb 2022.